Arimoclomol Production Cost Reports

The report provides a detailed analysis essential for establishing an arimoclomol production plant. It encompasses all critical aspects necessary for arimoclomol production, including the cost of arimoclomol production, arimoclomol plant cost, arimoclomol production costs, and the overall arimoclomol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an arimoclomol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Arimoclomol is a small-molecule pharmaceutical compound that is mainly used in the development of treatments for rare neurodegenerative and genetic disorders. It works by increasing the activity of heat shock proteins, which help cells manage stress and protect damaged proteins. It is primarily used in therapies for the treatment of conditions such as Niemann-Pick disease type C and amyotrophic lateral sclerosis (ALS). It is also utilised in the development of therapies for neurodegenerative and genetic disorders, where it helps support the body’s cellular stress response and improves the function of damaged proteins. It is commonly used in pharmaceutical research and clinical studies that focus on slowing disease progression and improving cellular function in patients with protein-misfolding disorders. It also finds application in medical research focused on understanding protein misfolding and cellular protection mechanisms. Additionally, it is used in pharmaceutical studies and clinical trials that explore new treatment options for neurodegenerative and metabolic disorders.

The primary factor that drives the market for arimoclomol is its demand in drug development programs focused on rare diseases and neurological conditions, which boosts its market expansion. Its application in the treatment of conditions such as amyotrophic lateral sclerosis (ALS), Niemann-Pick disease type C, and other neurological disorders significantly supports its demand in the medical and healthcare sectors. Its usage in clinical research, drug development programs, and experimental treatments for rare disease therapies to improve patient outcomes further boosts its demand in the healthcare and biotechnology sectors.

Its demand in the medical research industry for its potential role in improving lysosomal function and supporting treatments designed for metabolic and neurodegenerative disorders also drives its market growth. Moreover, advancements in drug development technologies, reliable pharmaceutical suppliers, sustainable production practices, and well-managed supply chains significantly influence industrial arimoclomol procurement. The increasing focus on developing treatments for rare diseases and protein-misfolding disorders further contributes to its market growth. Several factors, including the cost and availability of raw materials, regulatory approvals for clinical research, and strict pharmaceutical quality standards, also impact its procurement decisions.

Raw Material for Arimoclomol Production

According to the arimoclomol production plant project report, the major raw materials for arimoclomol production include piperidine, epichlorohydrin and 3-cyanopyridine.

Production Process of Arimoclomol

The extensive arimoclomol production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of arimoclomol citrate begins with converting 3-cyanopyridine into a suitable pyridine-3-carboximidoyl chloride N-oxide core, which provides the activated pyridine scaffold needed for further functionalization. In parallel, epichlorohydrin is reacted with piperidine to build the 2-hydroxy-3-piperidin-1-ylpropyl side chain through nucleophilic opening of the epoxide ring, which forms a piperidinylpropane intermediate bearing a terminal hydroxyl group. Then, this side chain intermediate is coupled with the activated pyridine N-oxide derivative to form arimoclomol, which creates the main ether linkage between the pyridine ring and the piperidinylpropyl fragment. After formation of arimoclomol, the crude product is purified and then treated with citric acid, followed by final polishing to obtain arimoclomol citrate as the desired product.

Arimoclomol is a hydroxylamine derivative and a selective co-inducer of heat shock proteins, particularly HSP70. It appears as a solid powder and is hygroscopic in nature. The molecular formula of the compound is C14H20ClN3O3, and its molar mass is 314.79 g/mol. The density of the compound is around 1.32 g/cm³, and its boiling point is 539.2 degree Celsius at 760 mmHg. The flash point of the compound is around 279.9 degree Celsius. The compound is soluble in DMSO, ethanol, and DMF, and is sparingly soluble in water. The compound functions by prolonging the activation of Heat Shock Factor 1 (HSF1), thereby amplifying the expression of protective heat shock proteins under cellular stress conditions. It is recommended to handle the compound with appropriate protective measures, as it is hygroscopic and requires storage under cool, dry, and well-ventilated conditions to maintain stability and integrity.